Related Experiment Video

Updated: Aug 9, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Metabolic complications of HIV infection: translating research findings into clinical practice

Judith Currier

    AIDS Clinical Care
    |January 23, 2002
    PubMed

    Insights

    Metabolic complications, including lipoatrophy and fat accumulation, are significant challenges in HIV treatment. More research is needed to understand the impact of antiretroviral agents on lipid and glucose metabolism.

    Area of Science:

    • Cardiology
    • Infectious Diseases
    • Endocrinology

    Background:

    • Metabolic complications are a significant clinical challenge in managing HIV infection.
    • Current data are insufficient to guide clinicians on specific issues like lipoatrophy, fat accumulation, avascular necrosis, and breast enlargement.

    Discussion:

    • There is a critical need for a comprehensive assessment of the metabolic profiles of antiretroviral agents.
    • Understanding the impact of these drugs on lipid and glucose metabolism in treatment-naive patients is essential.

    Key Insights:

    • The limitations in current data highlight the need for further research into the causes and treatments of metabolic complications associated with HIV.
    • Basic information on the metabolic effects of all FDA-approved antiretroviral drugs is lacking.

    Outlook:

    • Future research should focus on elucidating the mechanisms by which antiretroviral agents cause metabolic abnormalities.
    • Developing novel therapeutic agents and optimal management strategies for HIV-associated metabolic complications requires a deeper understanding of these mechanisms.

    More Related Videos

    A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood06:28

    A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood

    Published on: August 12, 2016

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

    Published on: October 6, 2022

    Related Concept Videos

    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
    Complications of Diabetes Mellitus01:22

    Complications of Diabetes Mellitus

    Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
    Inhibitors of Virion Maturation and Assembly01:19

    Inhibitors of Virion Maturation and Assembly

    As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...